PALVELLA THERAPEUTICS INC (PVLA) — insider trading
Health Care · NASDAQ
PALVELLA THERAPEUTICS INC (PVLA) has 59 reported SEC Form 4 insider transactions in our data, including 28 open-market sales among the most recent 59 (latest 2026-09-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,148 | — | $0 | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,154 | — | $0 | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,654 | $153.24 | $253.5K | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 989 | $152.36 | $150.7K | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,659 | $151.16 | $250.8K | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,148 | $9.08 | $19.5K | Form 4 |
| 2026-09-16 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,154 | $7.14 | $15.4K | Form 4 |
| 2026-09-15 | JENKINS GEORGE M | Director | Open-market sale | 560 | $151.33 | $84.7K | Form 4 |
| 2026-09-15 | JENKINS GEORGE M | Director | Open-market sale | 263 | $150.40 | $39.6K | Form 4 |
| 2026-09-15 | JENKINS GEORGE M | Director | Open-market sale | 954 | $149.38 | $142.5K | Form 4 |
| 2026-09-14 | JENKINS GEORGE M | Director | Open-market sale | 1,560 | $153.10 | $238.8K | Form 4 |
| 2026-09-14 | JENKINS GEORGE M | Director | Open-market sale | 6,160 | $152.12 | $937.0K | Form 4 |
| 2026-09-14 | JENKINS GEORGE M | Director | Open-market sale | 5,632 | $151.46 | $853.0K | Form 4 |
| 2026-09-11 | JENKINS GEORGE M | Director | Open-market sale | 1,274 | $153.06 | $195.0K | Form 4 |
| 2026-09-11 | JENKINS GEORGE M | Director | Open-market sale | 4,577 | $151.72 | $694.4K | Form 4 |
| 2026-09-11 | JENKINS GEORGE M | Director | Open-market sale | 6,520 | $150.62 | $982.0K | Form 4 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | Director | Option exercise / conversion (derivative) | 313 | — | $0 | Form 4 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | Director | Open-market sale | 313 | $157.00 | $49.1K | Form 4 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | Director | Option exercise / conversion | 313 | $127.20 | $39.8K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,148 | — | $0 | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,154 | — | $0 | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 302 | $156.77 | $47.3K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 102 | $155.59 | $15.9K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 400 | $153.00 | $61.2K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,998 | $151.80 | $303.3K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,500 | $151.39 | $227.1K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,148 | $9.08 | $19.5K | Form 4 |
| 2026-08-19 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,154 | $7.14 | $15.4K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,148 | — | $0 | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,154 | — | $0 | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,911 | $150.25 | $287.1K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,029 | $149.27 | $153.6K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 840 | $148.40 | $124.7K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 522 | $147.14 | $76.8K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,148 | $9.08 | $19.5K | Form 4 |
| 2026-07-15 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,154 | $7.14 | $15.4K | Form 4 |
| 2026-06-29 | Pauls Matthew | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,148 | — | $0 | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,154 | — | $0 | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 25 | $112.23 | $2.8K | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 1,887 | $111.31 | $210.0K | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 2,390 | $110.26 | $263.5K | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,148 | $9.08 | $19.5K | Form 4 |
| 2026-06-17 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,154 | $7.14 | $15.4K | Form 4 |
| 2026-06-12 | Korenberg Matthew E | Officer (CFO, Treasurer) | Option exercise / conversion (derivative) | 1,000 | — | $0 | Form 4 |
| 2026-06-12 | Korenberg Matthew E | Officer (CFO, Treasurer) | Option exercise / conversion | 1,000 | $13.60 | $13.6K | Form 4 |
| 2026-06-10 | Wessel Tadd S. | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-06-10 | Davis Todd C | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-06-10 | Doux John | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-06-10 | HERON ELAINE J | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-06-10 | JENKINS GEORGE M | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-06-10 | KIRITSY CHRISTOPHER P | Director | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,148 | — | $0 | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,154 | — | $0 | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 48 | $111.90 | $5.4K | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 891 | $111.30 | $99.2K | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Open-market sale | 3,363 | $110.35 | $371.1K | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,148 | $9.08 | $19.5K | Form 4 |
| 2026-05-20 | Goin Kathleen | Officer (Chief Operating Officer) | Option exercise / conversion | 2,154 | $7.14 | $15.4K | Form 4 |
Ask the chat about PVLA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PALVELLA THERAPEUTICS INC (PVLA).
Last updated 2026-09-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.